CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
about
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldExpression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast CancerMediator kinase module and human tumorigenesisTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsTelomeric ORFS in Candida albicans: does mediator tail wag the yeast?Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8The Mediator complex and transcription regulationAssessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinasesTumor-suppressive effects of CDK8 in endometrial cancer cells.H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.Biomarker correlation network in colorectal carcinoma by tumor anatomic location.A systems biology approach to the global analysis of transcription factors in colorectal cancer.Fungal mediator tail subunits contain classical transcriptional activation domains.Retroviral cyclin controls cyclin-dependent kinase 8-mediated transcription elongation and reinitiation.A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease.Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionsiRNA-mediated silencing of CDK8 inhibits proliferation and growth in breast cancer cells.Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).Genomic insights into WNT/β-catenin signaling.Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells.Inhibitors of cyclin-dependent kinases as cancer therapeutics.Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8.2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19.CDK8 Kinase Activity Promotes Glycolysis.
P2860
Q24620628-32D6DF6A-3621-49DB-B2DD-23FBA19BF372Q26785389-D07DD620-7153-4FBD-8D95-C829001052E4Q26800203-8CE74F48-58AB-4791-AB8E-47AC59D63389Q26827580-C11D1B21-8313-4ED8-9DD0-63EC2F100ADCQ27024376-4C622915-1978-41A0-BDF7-166C6943F5A0Q27703668-934C8CEE-F979-4628-B0FD-00D7007DF046Q28266383-FA898E2F-7ED1-4C4C-8EDD-0AE9F0480E83Q28299679-0867033B-FEA9-4E5C-8D4A-2B60E32891B9Q28817622-32917830-5FA1-4557-A12D-0D08C3F5435FQ30539219-76D026C2-5BBC-43A8-9A40-41A2D53B3B41Q30836400-7CE9E593-8874-4F6D-9358-F41CF0D69BA8Q33808553-960F9C90-F1F4-4065-9D66-79A302792103Q34361370-3728AED7-2B25-4563-85B0-305465C6DBA2Q35214711-3038566F-D0E0-4938-AD3D-EECFA104FD01Q35641457-4AF94C96-6447-4F72-9757-20B710E841C8Q36367502-116E06B8-FB9A-426C-90C3-9364A9D405C9Q37139174-B72B00DD-4C31-459B-862F-1BED9905FFB3Q37452162-04A0BBD0-40A7-448E-B915-9919E293D7D1Q37565309-BD8F518B-F034-4448-BFFB-706F36997629Q38173593-00D13687-369E-4EB8-B363-D0DD833DD4B3Q38785642-4DA02A42-FBD1-42DC-87BA-B28681A19727Q39125016-9BF54F98-8626-4C97-9EA2-5BDCAAF0683BQ42141778-7AAD689C-DBEC-4A05-9475-C9A315AC64C8Q42695709-709F8586-4FEB-4776-96EA-87472D8A7CAFQ47129821-10AAF5DF-F312-4819-B9D7-C272840A0807
P2860
CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CDK8 expression in 470 colorec ...... erations and patient survival.
@ast
CDK8 expression in 470 colorec ...... erations and patient survival.
@en
CDK8 expression in 470 colorec ...... erations and patient survival.
@nl
type
label
CDK8 expression in 470 colorec ...... erations and patient survival.
@ast
CDK8 expression in 470 colorec ...... erations and patient survival.
@en
CDK8 expression in 470 colorec ...... erations and patient survival.
@nl
prefLabel
CDK8 expression in 470 colorec ...... erations and patient survival.
@ast
CDK8 expression in 470 colorec ...... erations and patient survival.
@en
CDK8 expression in 470 colorec ...... erations and patient survival.
@nl
P2093
P2860
P50
P356
P1476
CDK8 expression in 470 colorec ...... terations and patient survival
@en
P2093
Emeric Bojarski
Kaori Shima
Katsuhiko Nosho
Natsumi Irahara
Ron Firestein
William C Hahn
Yoshifumi Baba
P2860
P304
P356
10.1002/IJC.24908
P577
2010-06-01T00:00:00Z